AlloSource, Wright Medical Group enter supply and distribution agreement for FUSIONFLEX graft

Wright Medical Group, Inc., a global orthopaedic medical device company, today announced a supply and distribution agreement with AlloSource for FUSIONFLEX™ Bone Matrix, a unique bone repair scaffold for use in primary fusion procedures of the foot and ankle, as well as other orthopaedic bone grafting applications.

“Prepared fusion sites in the foot and ankle are never quite perfect”

FUSIONFLEX™ graft is a flexible cancellous scaffold that acts as a carrier and matrix for new bone repair. It offers the foot and ankle surgeon intraoperative flexibility to graft prepared fusion sites, provide carrying capacity for bone marrow aspirate, and create a matrix that will intimately conform to the fusion site.

"Prepared fusion sites in the foot and ankle are never quite perfect," said Dr. Chris Hyer, foot and ankle surgeon in Columbus, Ohio. "It makes sense to utilize a graft that conforms to the site and that generates the necessary intimate bone-to-bone contact."

Rick Swaim, Director of Biologics Marketing with Wright adds, "The fact that FUSIONFLEX™ graft fills that need, can also carry bone marrow, and is relatively low cost will allow utilization of this graft for many fusion procedures in an outpatient setting."

"For more than 10 years, Wright Medical has been an integral partner in safely delivering life-saving and life-enhancing allograft products to surgeons for use on the patients that need them," said Kevin Cmunt, AlloSource Executive Vice President. "We look forward to collaborating on the FUSIONFLEX™ graft and offering a new solution to the challenges of bone grafting."

With this distribution agreement for FUSIONFLEX™ graft, Wright and AlloSource further expand their long-standing relationship in the human tissue/DBM arena. Full commercial launch for FUSIONFLEX™ is planned for the first half of 2011.

FUSIONFLEX™ Bone Matrix will be made available in the U.S. and select international markets through Wright's direct and distributor-based sales force. The FUSIONFLEX™ graft is the latest addition to Wright's Biologics franchise, which includes products such as XPANSION®Micrografting System, PRO-DENSE® Injectable Regenerative Graft, PRO-STIM® Injectable Inductive Graft, GRAFTJACKET® Regenerative Tissue Matrix, OSTEOSET® T Medicated Bone Graft (not available in the U.S.), and the ALLOPURE® line of foot and ankle bone wedges.